These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30776151)

  • 1. A case off TTP temporally associated with cocaine use: Implications for treatment of suspected DITMA.
    Regner SR; Lerfald N
    J Clin Apher; 2019 Aug; 34(4):510-512. PubMed ID: 30776151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
    Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
    Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indicators Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies in a Canadian Apheresis Referral Center.
    Martin SD; McGinnis E; Smith TW
    Am J Clin Pathol; 2021 Nov; 156(6):1103-1112. PubMed ID: 34160013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cocaine-induced microangiopathic hemolytic anemia mimicking idiopathic thrombotic thrombocytopenic purpura: a case report and review of the literature.
    Odronic S; Quraishy N; Manroa P; Kier Y; Koo A; Figueroa P; Hamilton A
    J Clin Apher; 2014 Oct; 29(5):284-9. PubMed ID: 24753113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
    Shibagaki Y; Fujita T
    Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on thrombotic thrombocytopenic purpura.
    Osborn JD; Rodgers GM
    Clin Adv Hematol Oncol; 2011 Jul; 9(7):531-6. PubMed ID: 22402460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Frontline clinical practice for thrombotic thrombocytopenic purpura].
    Miyakawa Y
    Rinsho Ketsueki; 2020; 61(9):1331-1337. PubMed ID: 33162533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia.
    George JN; Charania RS
    Semin Thromb Hemost; 2013 Mar; 39(2):153-60. PubMed ID: 23390027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies: Lessons learned from a 14-year retrospective study.
    Tau J; Fernando LP; Munoz MC; Poh C; Krishnan VV; Dwyre DM
    Ther Apher Dial; 2023 Feb; 27(1):136-145. PubMed ID: 35501999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New developments in treatment modalities of thrombotic thrombocytopenic purpura].
    Matsumoto M
    Rinsho Ketsueki; 2017; 58(10):2081-2086. PubMed ID: 28978852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.
    Shenkman B; Einav Y
    Autoimmun Rev; 2014; 13(4-5):584-6. PubMed ID: 24418304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombotic microangiopathies].
    Nielsen OJ; Friis-Hansen L
    Ugeskr Laeger; 2009 Nov; 171(49):3614-20. PubMed ID: 19954703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASFA Category IV becomes Category I: Idiopathic thrombotic thrombocytopenic purpura in a patient with presumed gemcitabine-induced thrombotic microangiopathy.
    Bittar PG; Nickolich MS; Onwuemene OA
    J Clin Apher; 2018 Jun; 33(3):423-426. PubMed ID: 28940604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
    Williams LA; Marques MB;
    Am J Clin Pathol; 2016 Feb; 145(2):158-65. PubMed ID: 27124904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombotic microangiopathy].
    Schmidt T; Huber TB
    Med Klin Intensivmed Notfmed; 2023 Feb; 118(1):14-20. PubMed ID: 36633606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
    Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time from suspected thrombotic thrombocytopenic purpura to initiation of plasma exchange and impact on survival: A 10-year provincial retrospective cohort study.
    Sawler D; Parker A; Britto J; Goodyear MD; Sun HL
    Thromb Res; 2020 Sep; 193():53-59. PubMed ID: 32521335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.
    Clark WF
    Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of a clinical prediction score for thrombotic thrombocytopenic purpura in an independent cohort.
    Bentley MJ; Wilson AR; Rodgers GM
    Vox Sang; 2013 Nov; 105(4):313-8. PubMed ID: 23662653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.